Viewing Study NCT03574220


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:21 AM
Study NCT ID: NCT03574220
Status: WITHDRAWN
Last Update Posted: 2020-04-07
First Post: 2018-06-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pembrolizumab After Lung SBRT for Medically Inoperable Early Stage Non-small Cell Lung Cancer
Sponsor: Case Comprehensive Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module